Increase in Healthcare AI Will Help Mitigate Risks and Achieve Better Patient Outcomes

 

With the world of healthcare seeing rapid evolution and where every decision counts, the integration of AI and machine learning models into clinical practice is heralding a new era of precision and efficiency. These innovative tools hold the promise of revolutionizing patient care by seamlessly integrating into EMRs bridging crucial gaps in diagnosis and treatment. Through providing decision-making support to healthcare providers in real-time, they hold the potential to mitigate the risks of incorrect diagnoses, treatment delays, and ensuring timely interventions for patients in need. Additionally, by aiding in the selection of appropriate diagnostic tests and facilitating the escalation of care when necessary, these technologies can significantly enhance patient outcomes.

The data generated by these AI tools lays the foundation for the development of predictive models, enabling healthcare professionals to anticipate patient outcomes and healthcare costs with greater accuracy. As these models continue to evolve and utilize information from expansive datasets, they become adept at predicting better patient outcomes and the probability of malpractice.

Dr. Arpita Hazra, the Clinical Patient Safety Data Specialist for Healthcare Risk Advisors, stated how this relationship between technology and healthcare will help improve clinical decision-making and expand patient safety to reduce the burden on healthcare providers. She offered some insights into the potential of AI and machine learning to reshape the future of healthcare.

Dr. Hazra’s Thoughts on Patient Outcomes

“Artificial intelligence and machine-learning models can be used to create clinical decision-making support tools that can integrate into the EMR, which can help fill care gaps in busy healthcare settings. This will reduce the incidence of incorrect diagnosis, reduce the delay in diagnosis and delay in treatment for patients, help the providers in ordering the correct diagnostic tests, and help escalate the patient’s care when needed.”

“The data collected from these kind of tools can be used to create machine learning-based predictive models. The more and more data that gets collected in these tools will make this tool more efficient and also help predict the patient’s outcome, the healthcare costs, the probability of malpractice claims.”

Article written by Alexandra Simon.

Follow us on social media for the latest updates in B2B!

Image

Latest

Doable
Rethinking Leadership: Why “Doable” Might Be the Most Powerful Strategy in Education Today
April 3, 2026

At a time when educator burnout is rising and schools across the U.S. are facing ongoing teacher shortages, leaders are being forced to rethink what sustainable success actually looks like. Research shows that teacher attrition is closely tied to working conditions, job-related stress, and workload demands. As districts push for innovation, data-driven instruction, and…

Read More
Casey Brown
From Poverty to Pricing Power | Why Great Companies Undercharge
April 2, 2026

Casey Brown didn’t grow up thinking she would become an entrepreneur. She grew up in a blue-collar family where money was always tight — close enough to the edge that the fear of poverty shaped many of her early decisions. That fear led her into engineering, into corporate America, and eventually into a moment…

Read More
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
Nightingales Summit: Empowering the Next Generation of Nigerian Nurses
April 2, 2026

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

Read More
Oncology
From Denial to Access: Rethinking Oncology Care Through AI, Clinical Trials, and Patient-Centered Innovation
April 1, 2026

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…

Read More